<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34491878</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>29</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections.</ArticleTitle>
        <Pagination>
          <StartPage>1964317</StartPage>
          <MedlinePgn>1964317</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">1964317</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2021.1964317</ELocationID>
        <Abstract>
          <AbstractText>Eliminating diarrheal diseases as a leading cause of childhood morbidity and mortality in low- and middle-income countries (LMICs) will require multiple intervention strategies. In this review, we spotlight a series of preclinical studies investigating the potential of orally administered monoclonal secretory IgA (SIgA) antibodies (MAbs) to reduce disease associated with three enteric bacterial pathogens: <i>Campylobacter jejuni</i>, enterotoxigenic <i>Escherichia coli</i> (ETEC), and invasive <i>Salmonella enterica</i> serovar Typhimurium. IgA MAbs targeting bacterial surface antigens (flagella, adhesins, and lipopolysaccharide) were generated from mice, humanized mice, and human tonsillar B cells. Recombinant SIgA1 and/or SIgA2 derivates of those MAbs were purified from supernatants following transient transfection of 293 cells with plasmids encoding antibody heavy and light chains, J-chain, and secretory component (SC). When administered to mice by gavage immediately prior to (or admixed with) the bacterial challenge, SIgA MAbs reduced infection <i>C. jejuni</i>, ETEC, and <i>S</i>. Typhimurium infections. Fv-matched IgG1 MAbs by comparison were largely ineffective against <i>C. jejuni</i> and <i>S</i>. Typhimurium under the same conditions, although they were partially effective against ETEC. While these findings highlight future applications of orally administered SIgA, the studies also underscored the fundamental challenges associated with using MAbs as prophylactic tools against enteric bacterial diseases.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Richards</LastName>
            <ForeName>Angelene</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-8189-4653</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, University at Albany School, Albany, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baranova</LastName>
            <ForeName>Danielle</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0003-2318-428X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, University at Albany School, Albany, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mantis</LastName>
            <ForeName>Nicholas J</ForeName>
            <Initials>NJ</Initials>
            <Identifier Source="ORCID">0000-0002-5083-8640</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, University at Albany School, Albany, NY, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R03 AI119647</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>09</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007071">Immunoglobulin A, Secretory</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000942" MajorTopicYN="N">Antigens, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054307" MajorTopicYN="Y">Enterotoxigenic Escherichia coli</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007071" MajorTopicYN="N">Immunoglobulin A, Secretory</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012486" MajorTopicYN="N">Salmonella typhimurium</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Enteric</Keyword>
        <Keyword MajorTopicYN="Y">antibody</Keyword>
        <Keyword MajorTopicYN="Y">infection</Keyword>
        <Keyword MajorTopicYN="Y">prophylactic</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>7</Day>
          <Hour>17</Hour>
          <Minute>18</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34491878</ArticleId>
        <ArticleId IdType="pmc">PMC9103515</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2021.1964317</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209–8. doi:10.1016/S0140-6736(13)60844-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(13)60844-2</ArticleId>
            <ArticleId IdType="pubmed">23680352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Platts-Mills JA, Liu J, Rogawski ET, Kabir F, Lertsethtakarn P, Siguas M, Khan SS, Praharaj I, Murei A, Nshama R, et al. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Health. 2018;6(12):e1309–e18. doi:10.1016/S2214-109X(18)30349-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2214-109X(18)30349-8</ArticleId>
            <ArticleId IdType="pmc">PMC6227251</ArticleId>
            <ArticleId IdType="pubmed">30287127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kasumba IN, Pulford CV, Perez-Sepulveda BM, Sen S, Sayed N, Permala-Booth J, Livio S, Heavens D, Low R, Hall N, et al. Characteristics of Salmonella recovered from stools of children enrolled in the global enteric multicenter study. Clin Infect Dis. 2021. doi:10.1093/cid/ciab051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciab051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pulford CV, Perez-Sepulveda BM, Canals R, Bevington JA, Bengtsson RJ, Wenner N, Rodwell EV, Kumwenda B, Zhu X, Bennett RJ, et al. Stepwise evolution of Salmonella Typhimurium ST313 causing bloodstream infection in Africa. Nat Microbiol. 2021;6(3):327–38. doi:10.1038/s41564-020-00836-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41564-020-00836-1</ArticleId>
            <ArticleId IdType="pmc">PMC8018540</ArticleId>
            <ArticleId IdType="pubmed">33349664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brandtzaeg P.
Mucosal immunity: integration between mother and the breast-fed infant. Vaccine. 2003;21:3382–88. doi:10.1016/S0264-410X(03)00338-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0264-410X(03)00338-4</ArticleId>
            <ArticleId IdType="pubmed">12850345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hennet T, Borsig L. Breastfed at Tiffany’s. Trends Biochem Sci. 2016;41:508–18. doi:10.1016/j.tibs.2016.02.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2016.02.008</ArticleId>
            <ArticleId IdType="pubmed">27093946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Labbok MH, Clark D, Goldman AS. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol. 2004;4:565–72. doi:10.1038/nri1393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri1393</ArticleId>
            <ArticleId IdType="pubmed">15229475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz L, Espinosa-Martos I, García-Carral C, Manzano S, McGuire MK, Meehan CL, McGuire MA, Williams JE, Foster J, Sellen DW, et al. What’s Normal? Immune Profiling of Human Milk from Healthy Women Living in Different Geographical and Socioeconomic Settings. Front Immunol. 2017;8. doi:10.3389/fimmu.2017.00696.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.00696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brandtzaeg P. The mucosal immune system and its integration with the mammary glands. J Pediatr. 2010;156(2):S8–15. doi:10.1016/j.jpeds.2009.11.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpeds.2009.11.014</ArticleId>
            <ArticleId IdType="pubmed">20105666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGuire MK, Randall AZ, Seppo AE, Jarvinen KM, Meehan CL, Gindola D, Williams JE, Sellen DW, Kamau-Mbuthia EW, Kamundia EW, et al. Multipathogen analysis of IgA and IgG antigen specificity for selected pathogens in milk produced by women from diverse geographical regions: the INSPIRE study. Front Immunol. 2020;11:614372. doi:10.3389/fimmu.2020.614372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2020.614372</ArticleId>
            <ArticleId IdType="pmc">PMC7905217</ArticleId>
            <ArticleId IdType="pubmed">33643297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gopalakrishna KP, Hand TW. Influence of maternal milk on the neonatal intestinal microbiome. Nutrients. 2020;12(3):823. doi:10.3390/nu12030823.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nu12030823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roux ME, McWilliams M, Phillips-Quagliata JM, Weisz-Carrington P, Lamm ME. Origin of IgA-secreting plasma cells in the mammary gland. J Exp Med. 1977;146:1311–22. doi:10.1084/jem.146.5.1311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.146.5.1311</ArticleId>
            <ArticleId IdType="pmc">PMC2180976</ArticleId>
            <ArticleId IdType="pubmed">925605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilson E, Butcher EC. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med. 2004;200:805–09. doi:10.1084/jem.20041069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20041069</ArticleId>
            <ArticleId IdType="pmc">PMC2211970</ArticleId>
            <ArticleId IdType="pubmed">15381732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirkwood CD, Ma LF, Carey ME, Steele AD. The rotavirus vaccine development pipeline. Vaccine. 2019;37:7328–35. doi:10.1016/j.vaccine.2017.03.076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2017.03.076</ArticleId>
            <ArticleId IdType="pmc">PMC6892263</ArticleId>
            <ArticleId IdType="pubmed">28396207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amour C, Gratz J, Mduma E, Svensen E, Rogawski ET, McGrath M, Seidman, JC, McCormick, BJ, Shrestha, S, Samie, A, Mahfuz, M, Qureshi, S, Hotwani, A, Babji, S, Trigoso, DR, Lima, AA, Bodhidatta, L, Bessong, P, Ahmed, T, Shakoor, S, Kang, G, Kosek, M, Guerrant, RL, Lang, D, Gottlieb, M, Houpt, ER, Platts-Mills, JA. Epidemiology and impact of campylobacter infection in children in 8 low-resource settings: results from the MAL-ED study. Clin Infect Dis. 2016;63:1171–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5064165</ArticleId>
            <ArticleId IdType="pubmed">27501842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Platts-Mills JA, Kosek M. Update on the burden of Campylobacter in developing countries. Curr Opin Infect Dis. 2014;27:444–50. doi:10.1097/QCO.0000000000000091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QCO.0000000000000091</ArticleId>
            <ArticleId IdType="pmc">PMC4542018</ArticleId>
            <ArticleId IdType="pubmed">25023741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riddle MS, Chen WH, Kirkwood CD, MacLennan CA. Update on vaccines for enteric pathogens. Clin Microbiol Infect. 2018;24:1039–45. doi:10.1016/j.cmi.2018.06.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2018.06.023</ArticleId>
            <ArticleId IdType="pubmed">29964231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walker R, Kaminski RW, Porter C, Choy RKM, White JA, Fleckenstein JM, Cassels F, Bourgeois L. Vaccines for protecting infants from bacterial causes of diarrheal disease. Microorganisms. 2021;9. doi:10.3390/microorganisms9071382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/microorganisms9071382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Virdi V, Palaci J, Laukens B, Ryckaert S, Cox E, Vanderbeke E, Depicker A, Callewaert N. Yeast-secreted, dried and food-admixed monomeric IgA prevents gastrointestinal infection in a piglet model. Nat Biotechnol. 2019;37:527–30. doi:10.1038/s41587-019-0070-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41587-019-0070-x</ArticleId>
            <ArticleId IdType="pmc">PMC6544532</ArticleId>
            <ArticleId IdType="pubmed">30936561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar N, Arthur CP, Ciferri C, Matsumoto ML. Structure of the secretory immunoglobulin A core. Science. 2020;367(6481):1008–14. doi:10.1126/science.aaz5807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aaz5807</ArticleId>
            <ArticleId IdType="pubmed">32029686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar Bharathkar S, Parker BW, Malyutin AG, Haloi N, Huey-Tubman KE, Tajkhorshid E, Stadtmueller BM. The structures of Secretory and dimeric Immunoglobulin A. Elife. 2020;9. doi:10.7554/eLife.56098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.56098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stadtmueller BM, Huey-Tubman KE, Lopez CJ, Yang Z, Hubbell WL, Bjorkman PJ. The structure and dynamics of secretory component and its interactions with polymeric immunoglobulins. Elife. 2016;5. doi:10.7554/eLife.10640.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.10640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Sousa-Pereira P, Woof JM. IgA: structure, function, and developability. Antibodies (Basel). 2019;8(4):57. doi:10.3390/antib8040057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/antib8040057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005;206:32–63. doi:10.1111/j.0105-2896.2005.00283.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.0105-2896.2005.00283.x</ArticleId>
            <ArticleId IdType="pubmed">16048541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stokes CR, Soothill JF, Turner MW. Immune exclusion is a function of IgA. Nature. 1975;255:745–46. doi:10.1038/255745a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/255745a0</ArticleId>
            <ArticleId IdType="pubmed">1169692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mantis NJ, Rol N, Corthesy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011;4:603–11. doi:10.1038/mi.2011.41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mi.2011.41</ArticleId>
            <ArticleId IdType="pmc">PMC3774538</ArticleId>
            <ArticleId IdType="pubmed">21975936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Binsker U, Lees JA, Hammond AJ, Weiser JN. Immune exclusion by naturally acquired secretory IgA against pneumococcal pilus-1. J Clin Invest. 2020;130:927–41. doi:10.1172/JCI132005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI132005</ArticleId>
            <ArticleId IdType="pmc">PMC6994158</ArticleId>
            <ArticleId IdType="pubmed">31687974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forbes SJ, Bumpus T, McCarthy EA, Corthesy B, Mantis NJ. Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. mBio. 2011;2:e00042–11. doi:10.1128/mBio.00042-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00042-11</ArticleId>
            <ArticleId IdType="pmc">PMC3101778</ArticleId>
            <ArticleId IdType="pubmed">21610121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moor K, Diard M, Sellin ME, Felmy B, Wotzka SY, Toska A, Bakkeren E, Arnoldini M, Bansept F, Co AD. High-avidity IgA protects the intestine by enchaining growing bacteria. Nature. 2017;544:498–502. doi:10.1038/nature22058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature22058</ArticleId>
            <ArticleId IdType="pubmed">28405025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding M, Yang B, Ross RP, Stanton C, Zhao J, Zhang H, Chen W. Crosstalk between sIgA-Coated Bacteria in Infant Gut and Early-Life Health. Trends Microbiol. 2021;29:725–35. doi:10.1016/j.tim.2021.01.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2021.01.012</ArticleId>
            <ArticleId IdType="pubmed">33602613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catanzaro JR, Strauss JD, Bielecka A, Porto AF, Lobo FM, Urban A, Schofield WB, Palm NW. IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM. Sci Rep. 2019;9(1):13574. doi:10.1038/s41598-019-49923-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-49923-2</ArticleId>
            <ArticleId IdType="pmc">PMC6753154</ArticleId>
            <ArticleId IdType="pubmed">31537840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang C, Chen-Liaw A, Moran TM, Cerutti A, Faith JJ. 
Immunoglobulin a antibody composition is sculpted to bind the self gut microbiome. bioRxiv
2020:2020.11.30.405332.</Citation>
        </Reference>
        <Reference>
          <Citation>Schnee AE, Petri WA Jr.. 
Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries. Curr Opin Infect Dis. 2017;30(3):322–28. doi:10.1097/QCO.0000000000000364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QCO.0000000000000364</ArticleId>
            <ArticleId IdType="pmc">PMC5560167</ArticleId>
            <ArticleId IdType="pubmed">28157786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirkpatrick BD, Tribble DR. Update on human Campylobacter jejuni infections. Curr Opin Gastroenterol. 2011;27(1):1–7. doi:10.1097/MOG.0b013e3283413763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MOG.0b013e3283413763</ArticleId>
            <ArticleId IdType="pubmed">21124212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, Operario DJ, Uddin J, Ahmed S, Alonso PL. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016;388(10051):1291–301. doi:10.1016/S0140-6736(16)31529-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)31529-X</ArticleId>
            <ArticleId IdType="pmc">PMC5471845</ArticleId>
            <ArticleId IdType="pubmed">27673470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tribble DR, Baqar S, Scott DA, Oplinger ML, Trespalacios F, Rollins D, Walker RI, Clements JD, Walz S, Gibbs P. Assessment of the duration of protection in campylobacter jejuni experimental infection in humans. Infect Immun. 2010;78(4):1750–59. doi:10.1128/IAI.01021-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01021-09</ArticleId>
            <ArticleId IdType="pmc">PMC2849408</ArticleId>
            <ArticleId IdType="pubmed">20086085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz-Palacios GM, Calva JJ, Pickering LK, Lopez-Vidal Y, Volkow P, Pezzarossi H, West MS. Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk. J Pediatr. 1990;116(5):707–13. doi:10.1016/S0022-3476(05)82652-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-3476(05)82652-6</ArticleId>
            <ArticleId IdType="pubmed">2329419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, Guerry P. A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol Microbiol. 2001;40(3):769–77. doi:10.1046/j.1365-2958.2001.02431.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2958.2001.02431.x</ArticleId>
            <ArticleId IdType="pubmed">11359581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hickey TE, Majam G, Guerry P. Intracellular survival of campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect Immun. 2005;73(8):5194–97. doi:10.1128/IAI.73.8.5194-5197.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.73.8.5194-5197.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1201269</ArticleId>
            <ArticleId IdType="pubmed">16041038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barrero-Tobon AM, Hendrixson DR. Flagellar biosynthesis exerts temporal regulation of secretion of specific Campylobacter jejuni colonization and virulence determinants. Mol Microbiol. 2014;93:957–74. doi:10.1111/mmi.12711.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/mmi.12711</ArticleId>
            <ArticleId IdType="pmc">PMC4150830</ArticleId>
            <ArticleId IdType="pubmed">25041103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerry P. Campylobacter flagella: not just for motility. Trends Microbiol. 2007;15:456–61. doi:10.1016/j.tim.2007.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2007.09.006</ArticleId>
            <ArticleId IdType="pubmed">17920274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lertsethtakarn P, Ottemann KM, Hendrixson DR. Motility and chemotaxis in Campylobacter and Helicobacter. Annu Rev Microbiol. 2011;65:389–410. doi:10.1146/annurev-micro-090110-102908.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-micro-090110-102908</ArticleId>
            <ArticleId IdType="pmc">PMC6238628</ArticleId>
            <ArticleId IdType="pubmed">21939377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tegtmeyer N, Sharafutdinov I, Harrer A, Soltan Esmaeili D, Linz B, Backert S. Campylobacter Virulence Factors and Molecular Host-Pathogen Interactions. Curr Top Microbiol Immunol. 2021;431:169–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33620652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao R, Burr DH, Doig P, Trust TJ, Niu H, Guerry P. Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol Microbiol. 1994;14:883–93. doi:10.1111/j.1365-2958.1994.tb01324.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.1994.tb01324.x</ArticleId>
            <ArticleId IdType="pubmed">7715450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takata T, Fujimoto S, Amako K. Isolation of nonchemotactic mutants of Campylobacter jejuni and their colonization of the mouse intestinal tract. Infect Immun. 1992;60:3596–600. doi:10.1128/iai.60.9.3596-3600.1992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.60.9.3596-3600.1992</ArticleId>
            <ArticleId IdType="pmc">PMC257366</ArticleId>
            <ArticleId IdType="pubmed">1500167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pavlovskis OR, Rollins DM, Haberberger RL Jr., Green AE, Habash L, Strocko S, Walker, RI. Significance of flagella in colonization resistance of rabbits immunized with Campylobacter spp. Infect Immun. 1991;59:2259–64. doi:10.1128/iai.59.7.2259-2264.1991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.59.7.2259-2264.1991</ArticleId>
            <ArticleId IdType="pmc">PMC258004</ArticleId>
            <ArticleId IdType="pubmed">2050397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ. Experimental Campylobacter jejuni infection in humans. J Infect Dis. 1988;157:472–79. doi:10.1093/infdis/157.3.472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/157.3.472</ArticleId>
            <ArticleId IdType="pubmed">3343522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thibault P, Logan SM, Kelly JF, Brisson JR, Ewing CP, Trust TJ, Guerry, P. Identification of the carbohydrate moieties and glycosylation motifs in Campylobacter jejuni flagellin. J Biol Chem. 2001;276:34862–70. doi:10.1074/jbc.M104529200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M104529200</ArticleId>
            <ArticleId IdType="pubmed">11461915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chintoan-Uta C, Cassady-Cain RL, Stevens MP. Evaluation of flagellum-related proteins FliD and FspA as subunit vaccines against Campylobacter jejuni colonisation in chickens. Vaccine. 2016;34:1739–43. doi:10.1016/j.vaccine.2016.02.052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2016.02.052</ArticleId>
            <ArticleId IdType="pmc">PMC4820088</ArticleId>
            <ArticleId IdType="pubmed">26921781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perruzza L, Jaconi S, Lombardo G, Pinna D, Strati F, Morone D, Seehusen F, Hu Y, Bajoria S, Xiong J, Kumru OS, Joshi SB, Volkin DB, Piantanida R, Benigni F, Grassi F, Corti D, Pizzuto MS. Prophylactic activity of orally administered FliD-Reactive monoclonal siga against campylobacter infection. Front Immunol. 2020;11:1011. doi:10.3389/fimmu.2020.01011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2020.01011</ArticleId>
            <ArticleId IdType="pmc">PMC7296071</ArticleId>
            <ArticleId IdType="pubmed">32582158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerrant RL, DeBoer MD, Moore SR, Scharf RJ, Lima AA. The impoverished gut–a triple burden of diarrhoea, stunting and chronic disease. Nat Rev Gastroenterol Hepatol. 2013;10:220–29. doi:10.1038/nrgastro.2012.239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrgastro.2012.239</ArticleId>
            <ArticleId IdType="pmc">PMC3617052</ArticleId>
            <ArticleId IdType="pubmed">23229327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fleckenstein JM, Kuhlmann FM. Enterotoxigenic Escherichia coli infections. Curr Infect Dis Rep. 2019;21:9. doi:10.1007/s11908-019-0665-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11908-019-0665-x</ArticleId>
            <ArticleId IdType="pmc">PMC6508951</ArticleId>
            <ArticleId IdType="pubmed">30830466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riaz S, Steinsland H, Hanevik K. Human mucosal IgA immune responses against enterotoxigenic Escherichia coli. Pathogens. 2020;9(9):714. doi:10.3390/pathogens9090714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pathogens9090714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giuntini S, Stoppato M, Sedic M, Ejemel M, Pondish JR, Wisheart D, Schiller ZA, Thomas WD Jr, Barry EM, Cavacini LA, Klempner MS, Wang Y. Identification and characterization of human monoclonal antibodies for immunoprophylaxis against enterotoxigenic Escherichia coli infection. Infect Immun. 2018;86(8):e00355-18. doi: 10.1128/IAI.00355-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00355-18</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu Y, Kumru OS, Xiong J, Antunez LR, Hickey J, Wang Y, Cavacini L, Klempner M, Joshi SB, Volkin DB. Preformulation characterization and stability assessments of secretory IgA monoclonal antibodies as potential candidates for passive immunization by oral administration. J Pharm Sci. 2020;109(1):407–21. doi:10.1016/j.xphs.2019.07.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.xphs.2019.07.018</ArticleId>
            <ArticleId IdType="pmc">PMC6941217</ArticleId>
            <ArticleId IdType="pubmed">31369743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoppato M, Gaspar C, Regeimbal J, Nunez RG, Giuntini S, Schiller ZA, Gawron MA, Pondish JR, Martin JC, Schneider MI, et al. Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model. Vaccine. 2020;38(10):2333–39. doi:10.1016/j.vaccine.2020.01.064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2020.01.064</ArticleId>
            <ArticleId IdType="pubmed">32008877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallace AL, Schneider MI, Toomey JR, Schneider RM, Klempner MS, Wang Y, Cavacini LA. IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability. Vaccine. 2020;38:7490–97. doi:10.1016/j.vaccine.2020.09.070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2020.09.070</ArticleId>
            <ArticleId IdType="pmc">PMC7604562</ArticleId>
            <ArticleId IdType="pubmed">33041102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teh AY, Cavacini L, Hu Y, Kumru OS, Xiong J, Bolick DT, Joshi SB, Grünwald-Gruber C, Altmann F, Klempner M. Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants. Gut Microbes. 2021;13(1):1–14. doi:10.1080/19490976.2020.1859813.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/19490976.2020.1859813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darsley MJ, Chakraborty S, DeNearing B, Sack DA, Feller A, Buchwaldt C, Bourgeois AL, Walker R, Harro CD. The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease. Clin Vaccine Immunol. 2012;19(12):1921–31. doi:10.1128/CVI.00364-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CVI.00364-12</ArticleId>
            <ArticleId IdType="pmc">PMC3535858</ArticleId>
            <ArticleId IdType="pubmed">23035175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kariuki S, Mbae C, Van Puyvelde S, Onsare R, Kavai S, Wairimu C, Ngetich R, Clemens J, Dougan G. High relatedness of invasive multi-drug resistant non-typhoidal Salmonella genotypes among patients and asymptomatic carriers in endemic informal settlements in Kenya. PLoS Negl Trop Dis. 2020;14(8):e0008440. doi:10.1371/journal.pntd.0008440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0008440</ArticleId>
            <ArticleId IdType="pmc">PMC7425985</ArticleId>
            <ArticleId IdType="pubmed">32745137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivera-Chavez F, Baumler AJ. The pyromaniac inside you: Salmonella metabolism in the host gut. Annu Rev Microbiol. 2015;69:31–48. doi:10.1146/annurev-micro-091014-104108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-micro-091014-104108</ArticleId>
            <ArticleId IdType="pubmed">26002180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carter PB, Collins FM. The route of enteric infection in normal mice. J Exp Med. 1974;139:1189–203. doi:10.1084/jem.139.5.1189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.139.5.1189</ArticleId>
            <ArticleId IdType="pmc">PMC2139651</ArticleId>
            <ArticleId IdType="pubmed">4596512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivera-Chavez F, Lopez CA, Zhang LF, Garcia-Pastor L, Chavez-Arroyo A, Lokken KL, Tsolis RM, Winter SE, Bäumler AJ. Energy Taxis toward Host-Derived Nitrate Supports a Salmonella Pathogenicity Island 1-Independent Mechanism of Invasion. mBio. 2016;7(4). doi:10.1128/mBio.00960-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00960-16</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim CH, Voedisch S, Wahl B, Rouf SF, Geffers R, Rhen M, Pabst O. Independent bottlenecks characterize colonization of systemic compartments and gut lymphoid tissue by Salmonella. PLoS Pathog. 2014;10(7):e1004270. doi:10.1371/journal.ppat.1004270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1004270</ArticleId>
            <ArticleId IdType="pmc">PMC4117638</ArticleId>
            <ArticleId IdType="pubmed">25079958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richards AF, Doering JE, Lozito SA, Varrone JJ, Willsey GG, Pauly M, Whaley K, Zeitlin L, Mantis NJ. Inhibition of invasive Salmonella by orally administered IgA and IgG monoclonal antibodies. PLoS Negl Trop Dis. 2020;14(3):e0007803. doi:10.1371/journal.pntd.0007803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0007803</ArticleId>
            <ArticleId IdType="pmc">PMC7117778</ArticleId>
            <ArticleId IdType="pubmed">32203503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richards AF, Baranova DE, Pizzuto MS, Jaconi S, Willsey GG, Torres-Velez FJ, Doering JE, Benigni F, Mantis NJ. Recombinant human secretory iga induces Salmonella typhimurium agglutination and limits bacterial invasion into gut-associated lymphoid tissues. ACS Infect Dis. 2021;7(5):1221–35. doi:10.1021/acsinfecdis.0c00842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acsinfecdis.0c00842</ArticleId>
            <ArticleId IdType="pmc">PMC8154420</ArticleId>
            <ArticleId IdType="pubmed">33728898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forbes SJ, Eschmann M, Mantis NJ. Inhibition of Salmonella enterica serovar typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin a antibody. Infect Immun. 2008;76(9):4137–44. doi:10.1128/IAI.00416-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00416-08</ArticleId>
            <ArticleId IdType="pmc">PMC2519396</ArticleId>
            <ArticleId IdType="pubmed">18625740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forbes SJ, Martinelli D, Hsieh C, Ault JG, Marko M, Mannella CA, Mantis NJ. Association of a protective monoclonal IgA with the O antigen of Salmonella enterica serovar Typhimurium impacts type 3 secretion and outer membrane integrity. Infect Immun. 2012;80(7):2454–63. doi:10.1128/IAI.00018-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00018-12</ArticleId>
            <ArticleId IdType="pmc">PMC3416483</ArticleId>
            <ArticleId IdType="pubmed">22473607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amarasinghe JJ, D’Hondt RE, Waters CM, Mantis NJ. Exposure of Salmonella enterica Serovar typhimurium to a protective monoclonal IgA triggers exopolysaccharide production via a diguanylate cyclase-dependent pathway. Infect Immun. 2013;81:653–64. doi:10.1128/IAI.00813-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00813-12</ArticleId>
            <ArticleId IdType="pmc">PMC3584880</ArticleId>
            <ArticleId IdType="pubmed">23230292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun. 1992;60:1786–92. doi:10.1128/iai.60.5.1786-1792.1992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.60.5.1786-1792.1992</ArticleId>
            <ArticleId IdType="pmc">PMC257074</ArticleId>
            <ArticleId IdType="pubmed">1373399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michetti P, Porta N, Mahan MJ, Slauch JM, Mekalanos JJ, Blum AL, Kraehenbuhl J-P, Neutra MR. Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. Gastroenterology. 1994;107(4):915–23. doi:10.1016/0016-5085(94)90214-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0016-5085(94)90214-3</ArticleId>
            <ArticleId IdType="pubmed">7926481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Virdi V, Juarez P, Boudolf V, Depicker A. Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles. Cell Mol Life Sci. 2016;73(3):535–45. doi:10.1007/s00018-015-2074-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-015-2074-0</ArticleId>
            <ArticleId IdType="pubmed">26511868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khanal O, Lenhoff AM. Developments and opportunities in continuous biopharmaceutical manufacturing. mAbs. 2021;13:1903664. doi:10.1080/19420862.2021.1903664.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/19420862.2021.1903664</ArticleId>
            <ArticleId IdType="pmc">PMC8043180</ArticleId>
            <ArticleId IdType="pubmed">33843449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakanishi K, Matsuda M, Ida R, Hosokawa N, Kurohane K, Niwa Y, Kobayashi H, Imai Y. Lettuce-derived secretory IgA specifically neutralizes the Shiga toxin 1 activity. Planta. 2019;250(4):1255–64. doi:10.1007/s00425-019-03215-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00425-019-03215-1</ArticleId>
            <ArticleId IdType="pubmed">31222495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoger E, Fischer R, Moloney M, Ma JK. Plant molecular pharming for the treatment of chronic and infectious diseases. Annu Rev Plant Biol. 2014;65(1):743–68. doi:10.1146/annurev-arplant-050213-035850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-arplant-050213-035850</ArticleId>
            <ArticleId IdType="pubmed">24579993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jester B, Zhao H, Gewe M, Adame T, Perruzza L, Bolick D, Agosti, J, Khuong, N, Kuestner, R, Gamble C, Cruickshank K, Ferrara J, Lim R, Paddock T, Brady C, Ertel S, Zhang M, Tasch M, Saveria T, Doughty D, Marshall J, et al. Expression and manufacturing of protein therapeutics in spirulina. bioRxiv 2021:2021.01.25.427910.</Citation>
        </Reference>
        <Reference>
          <Citation>Baranova DE, Chen L, Destrempes M, Meade H, Mantis NJ. Passive immunity to vibrio cholerae O1 afforded by a human monoclonal IgA1 antibody expressed in milk. Pathogens and Immunity. 2020;5(1):89–116. doi:10.20411/pai.v5i1.370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.20411/pai.v5i1.370</ArticleId>
            <ArticleId IdType="pmc">PMC8204294</ArticleId>
            <ArticleId IdType="pubmed">34136728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu X, Pollock D, Duval M, Lewis C, Joseph K, Meade H, Stoger E, Fischer R, Moloney M. Neutralization of HIV by milk expressed antibody. J Acquir Immune Defic Syndr. 2013;62(1):10–16. doi:10.1097/QAI.0b013e318271c450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QAI.0b013e318271c450</ArticleId>
            <ArticleId IdType="pmc">PMC3531710</ArticleId>
            <ArticleId IdType="pubmed">23269241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bioley G, Monnerat J, Lotscher M, Vonarburg C, Zuercher A, Corthesy B. Plasma-derived polyreactive secretory-like IgA and IgM opsonizing Salmonella enterica typhimurium reduces invasion and gut tissue inflammation through agglutination. Front Immunol. 2017;8:1043. doi:10.3389/fimmu.2017.01043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.01043</ArticleId>
            <ArticleId IdType="pmc">PMC5581814</ArticleId>
            <ArticleId IdType="pubmed">28900429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lombana TN, Rajan S, Zorn JA, Mandikian D, Chen EC, Estevez A, Yip V, Bravo DD, Phung W, Farahi F. Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice. MAbs. 2019;11(6):1122–38. doi:10.1080/19420862.2019.1622940.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/19420862.2019.1622940</ArticleId>
            <ArticleId IdType="pmc">PMC6748581</ArticleId>
            <ArticleId IdType="pubmed">31122132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muscariello L, De Siena B, Marasco R. Lactobacillus cell surface proteins involved in interaction with mucus and extracellular matrix components. Curr Microbiol. 2020;77(12):3831–41. doi:10.1007/s00284-020-02243-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00284-020-02243-5</ArticleId>
            <ArticleId IdType="pmc">PMC7677277</ArticleId>
            <ArticleId IdType="pubmed">33079206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang YY, Schroeder HA, Nunn KL, Woods K, Anderson DJ, Lai SK, Cone RA. Diffusion of immunoglobulin g in shed vaginal epithelial cells and in cell-free regions of human cervicovaginal mucus. PLoS One. 2016;11:e0158338. doi:10.1371/journal.pone.0158338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0158338</ArticleId>
            <ArticleId IdType="pmc">PMC4928780</ArticleId>
            <ArticleId IdType="pubmed">27362256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrestha B, Schaefer A, Chavez EC, Kopp AJ, Jacobs TM, Moench TR, Lai SK. Engineering tetravalent IgGs with enhanced agglutination potencies for trapping vigorously motile sperm in mucin matrix. Acta Biomater. 2020;117:226–34. doi:10.1016/j.actbio.2020.09.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.actbio.2020.09.020</ArticleId>
            <ArticleId IdType="pmc">PMC8778962</ArticleId>
            <ArticleId IdType="pubmed">32937206</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
